Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
42,9 USD | -0,23% |
|
-11,45% | +44,86% |
10/06 | TANDEM DIABETES CARE, INC. : Oppenheimer conferma il rating Buy | ZM |
06/06 | Transcript : Tandem Diabetes Care, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 08:00 AM |
Attività
Numero di dipendenti: 2 400
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Supplies and Other
54,4
%
| - | - | 407 | 54,4 % | - |
Pump
50,1
%
| 432 | 53,9 % | 374 | 50,1 % | -13,34% |
Deferral for Tandem Choice Program
-3,4
%
| -4 | -0,4 % | -25 | -3,4 % | +607,44% |
Pump Rebate
-1,1
%
| - | - | -8 | -1,1 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
74,2
%
| 589 | 73,5 % | 555 | 74,2 % | -5,76% |
Non-United States
25,8
%
| 212 | 26,5 % | 193 | 25,8 % | -9,23% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Sheridan
CEO | Chief Executive Officer | 68 | 01/03/13 |
Leigh Vosseller
DFI | Director of Finance/CFO | 51 | 01/09/13 |
Shannon Hansen
CMP | Compliance Officer | 58 | 01/01/22 |
Jordan Pinsker
CTO | Chief Tech/Sci/R&D Officer | - | 26/04/21 |
Peter Rossiter
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/20 |
Michael Michaud
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/19 |
Susan Morrison
ADM | Chief Administrative Officer | 44 | 01/11/07 |
Rick Carpenter
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/12/21 |
Mark Novara
PRN | Corporate Officer/Principal | - | 13/11 |
Rizwan Pervez
LAW | General Counsel | - | 02/12/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 63 | 03/01/19 | |
Director/Board Member | 64 | 01/07/13 | |
John Sheridan
CEO | Chief Executive Officer | 68 | 01/03/13 |
Director/Board Member | 60 | 08/06/20 | |
Dick Allen
BRD | Director/Board Member | 79 | 01/07/07 |
Peyton Howell
BRD | Director/Board Member | 57 | 03/08/20 |
Director/Board Member | 50 | 01/01/21 | |
Myoung Cha
BRD | Director/Board Member | 47 | 15/06/22 |
Joao Malagueira
BRD | Director/Board Member | 58 | 15/06/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 64 589 518 | 64 094 203 ( 99,23 %) | 0 | 99,23 % |
Coordinate società
Tandem Diabetes Care, Inc.
12400 High Bluff Drive
92130, San Diego
+858 366 6900
http://www.tandemdiabetes.com![Indirizzo Tandem Diabetes Care, Inc.(TNDM)](https://cdn.zonebourse.com/static/address/38066231.png)
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+44,86% | 2,78 Mrd | |
-5,91% | 180 Mrd | |
-3,40% | 105 Mrd | |
-4,43% | 67,27 Mrd | |
-5,64% | 46,34 Mrd | |
+15,69% | 46,22 Mrd | |
+4,14% | 40,1 Mrd | |
+21,93% | 30,92 Mrd | |
-10,96% | 24,48 Mrd | |
+12,05% | 24,22 Mrd |
- Borsa valori
- Azioni
- Azione TNDM
- Società Tandem Diabetes Care, Inc.